The biotech company said it is well-stocked to supply its approved drugs for cystic fibrosis to patients. Meanwhile, it plans to implement virtual visits and ship drugs to participants in its ongoing trials, while pausing enrollment and delaying initiation in some.

LEAVE A REPLY

Please enter your comment!
Please enter your name here